# 20/20 Biolabs, Inc.: Form DEF 14A, filed Oct 21, 2026

- Company: [20/20 Biolabs, Inc.](/companies/aidx.md) (CIK 1139685)
- Form: DEF 14A
- Filed: 2026-10-21
- Accepted by EDGAR: Oct 21, 2026, 20:10 ET
- Period: 2026-12-09
- Accession: 0001213900-26-111346
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026111346/ea0309287-def14a_2020bio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1139685/000121390026111346/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1139685/000121390026111346/ea0309287-def14a_2020bio.htm

Filed Oct 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-111346. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.
